Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
InterDigital
IDCC
$9.08B
| $22.1M | 0.01% |
326,399
+11,072
| +4% | +$767K |
|
1502
JELD-WEN Holding
JELD
$165M
| $22.1M | 0.01% |
884,291
+63,140
| +8% | +$1.68M |
|
1503
FormFactor
FORM
$10.1B
| $22.1M | 0.01% |
592,900
-29,152
| -5% | -$1.08M |
|
|
SNBR
1504
DELISTED
Sleep Number
SNBR
| $22.1M | 0.01% |
236,753
-9,246
| -4% | -$917K |
|
1505
Progress Software
PRGS
$1.81B
| $22.1M | 0.01% |
449,725
+8,298
| +2% | +$382K |
|
1506
VictoryShares US Small Mid Cap Value Momentum ETF
USVM
$1.8B
| $22.1M | 0.01% |
314,495
+7,495
| +2% | +$530K |
|
1507
AtriCure
ATRC
$2.22B
| $22.1M | 0.01% |
317,124
+3,342
| +1% | +$257K |
|
1508
Sanmina
SANM
$11.3B
| $22.1M | 0.01% |
572,236
+2,223
| +0.4% | +$85.3K |
|
1509
PagerDuty
PD
$878M
| $22M | 0.01% |
531,252
+81,230
| +18% | +$3.44M |
|
1510
MYR Group
MYRG
$5.16B
| $22M | 0.01% |
221,120
-24,612
| -10% | -$2.42M |
|
1511
Stock Yards Bancorp
SYBT
$2.65B
| $22M | 0.01% |
374,645
+48,511
| +15% | +$2.48M |
|
|
VRE
1512
DELISTED
Veris Residential
VRE
| $22M | 0.01% |
1,282,941
-22,014
| -2% | -$383K |
|
|
PFC
1513
DELISTED
Premier Financial Corp. Common Stock
PFC
| $21.9M | 0.01% |
688,852
+32,327
| +5% | +$933K |
|
|
CPE
1514
DELISTED
Callon Petroleum Company
CPE
| $21.9M | 0.01% |
446,870
-74,969
| -14% | -$2.9M |
|
1515
City Holding Co
CHCO
$2.08B
| $21.9M | 0.01% |
281,209
+25,608
| +10% | +$1.94M |
|
1516
Sprouts Farmers Market
SFM
$8.1B
| $21.9M | 0.01% |
943,723
-52,820
| -5% | -$1.29M |
|
1517
Cytokinetics
CYTK
$10.6B
| $21.9M | 0.01% |
611,533
+100,229
| +20% | +$2.95M |
|
1518
Albany International
AIN
$1.84B
| $21.8M | 0.01% |
284,217
+11,642
| +4% | +$935K |
|
1519
Bilibili
BILI
$7.24B
| $21.8M | 0.01% |
328,786
+7,625
| +2% | +$653K |
|
1520
Aaon
AAON
$7.08B
| $21.7M | 0.01% |
498,200
+10,214
| +2% | +$443K |
|
1521
Greif
GEF
$5.1B
| $21.7M | 0.01% |
335,678
+16,370
| +5% | +$1.01M |
|
1522
J&J Snack Foods
JJSF
$1.7B
| $21.7M | 0.01% |
141,780
+3,330
| +2% | +$542K |
|
1523
Erie Indemnity
ERIE
$13.6B
| $21.7M | 0.01% |
121,393
+4,294
| +4% | +$777K |
|
|
INOV
1524
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $21.7M | 0.01% |
537,561
-15,625
| -3% | -$591K |
|
1525
Federal Signal
FSS
$7.71B
| $21.6M | 0.01% |
559,519
+22,867
| +4% | +$899K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.